Allergic rhinosinusitis. Allergic rhinosinusitis
Conditions
Interventions
Intervention 1: Intervention group: Olopatadine nasal spray 0.6% every 12 hours (made by Daroo Pakhsh Tehran). Intervention 2: Intervention group: Mometasone 50 mg nasal spray every 6 hours (made by C
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18 to 60 years Patients with confirmed allergic rhinosinusitis Written consent to enter the study Patient cooperation during the study Timely and correct use of medication by asking the patient Absence of abnormal nasal anatomy Absence of severe nasal congestion due to polyps, other lesions and obstructive masses Absence of respiratory infections Non-smokers Absence of upper and lower lung diseases affecting the final consumption or absorption of the nose Absence of symptoms of systemic diseases
Exclusion criteria
Exclusion criteria: People known for not responding to antihistamines Known intolerance or sensitivity to drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to treatment of olapatadine and mometasone spray groups. Timepoint: Before the intervention and on days 1, 3 and week 2 after starting the medication. Method of measurement: Sino Nasal Outcome Test 22 questionnaire.;Satisfaction of patients receiving olapatadine and mometasone spray groups. Timepoint: 2 weeks After starting the intervention. Method of measurement: 5 point scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEhsan Ebrahimzadeh
Sabzevar University of Medical Sciences
Outcome results
None listed